Trends in the Prevalence of Hypertensive Heart Disease in China From 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis.
age-period-cohort effect
hypertensive heart disease
joinpoint regression analysis
prevalence
trends
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
12
2021
accepted:
10
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
6
4
2022
Statut:
epublish
Résumé
To the best of our knowledge, no comprehensive estimates of the descriptive epidemiology of and trends in hypertensive heart disease (HHD) in China have been reported. In this study, the temporal trends in the prevalence of HHD in China from 1990 to 2019 were estimated using an age-period-cohort model. Data related to HHD burden were collected from the Global Burden of Disease Study 2019. From 1990 to 2019, HHD prevalence in China showed decreasing trends in both sexes combined (average annual percentage change [AAPC]: -0.2%, 95% confidence interval (CI: -0.3% to -0.2%) and in males (AAPC: -0.5%, 95% CI: -0.5% to -0.4%), but significant increases in the age groups of 15-19, 20-24, …, and 60-64 years. The age effect analysis showed an increase in HHD prevalence from 50 to 94 years in both males and females, the period effect analysis showed a slight increase in HHD prevalence from 2009 to 2019 in females, and the cohort effect analysis showed a consistent decline in HHD prevalence from earlier to later birth cohorts in both males and females.
Identifiants
pubmed: 35372212
doi: 10.3389/fpubh.2022.833345
pmc: PMC8966025
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
833345Informations de copyright
Copyright © 2022 Xu, Hu, Wang and Chen.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Hypertension. 2021 Apr;77(4):1223-1233
pubmed: 33583201
Public Health. 2019 Jul;172:70-80
pubmed: 31220754
Drug Alcohol Depend. 2013 Sep 1;132(1-2):140-8
pubmed: 23433898
Int J Environ Res Public Health. 2016 Aug 03;13(8):
pubmed: 27527195
Lancet. 2005 Nov 19;366(9499):1821-4
pubmed: 16298221
Curr Hypertens Rep. 2020 Feb 3;22(2):11
pubmed: 32016791
J Am Coll Cardiol. 1992 Aug;20(2):301-6
pubmed: 1634664
Stat Med. 2009 Dec 20;28(29):3670-82
pubmed: 19856324
Lancet. 2013 Jun 8;381(9882):1987-2015
pubmed: 23746901
Card Electrophysiol Clin. 2021 Mar;13(1):37-45
pubmed: 33516406
Cancer Epidemiol. 2019 Aug;61:95-103
pubmed: 31176961
Circulation. 2015 Jun 16;131(24):e535
pubmed: 26078378
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Cell Transplant. 2020 Jan-Dec;29:963689720920830
pubmed: 32393064
Circulation. 2018 May 29;137(22):2344-2356
pubmed: 29449338
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175